Suchergebnisse - "Oliva, Alessandra"

PubPharm (260)

101

Molecular Identification of New Cases of Human Dirofilariosis (Dirofilaria repens) in Italy

enthalten in: Pathogens (Basel, Switzerland) | 2021

von Gabrielli, S. | Mangano, V. | Furzi, F. | +9

102

Real-life use of tocilizumab with or without corticosteroid in hospitalized patients with moderate-to-severe COVID-19 pneumonia : A retrospective cohort study

enthalten in: PloS one | 2021

von Russo, G. | Solimini, A. | Zuccalà, P. | +16

103

Biofilm-Related Infections in Gram-Positive Bacteria and the Potential Role of the Long-Acting Agent Dalbavancin

enthalten in: Frontiers in microbiology | 2021

von Oliva, A. | Stefani, S. | Venditti, M. | +1

104

Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19

enthalten in: Frontiers in immunology | 2021

von Oliva, A. | Miele, M. | Di Timoteo, F. | +9

105

Challenges in the Microbiological Diagnosis of Implant-Associated Infections : A Summary of the Current Knowledge

enthalten in: Frontiers in microbiology | 2021

von Oliva, A. | Miele, M. | Al Ismail, D. | +8

CommentIn: Front Microbiol. 2022 Feb 24;12:814945. - PMID 35345543

106

CURB-65 plus hypoalbuminemia : a new score system for prediction of the in-hospital mortality risk in patients with SARS-CoV-2 pneumonia

enthalten in: Le infezioni in medicina | 2021

von Oliva, A. | Borrazzo, C. | Mascellino, M. | +10

107

Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent

enthalten in: European journal of clinical investigation | 2021

von Ceccarelli, G. | Alessandri, F. | Oliva, A. | +6

108

Overview of the Main Anti-SARS-CoV-2 Vaccines : Mechanism of Action, Efficacy and Safety

enthalten in: Infection and drug resistance | 2021

von Mascellino, M. | Di Timoteo, F. | De Angelis, M. | +1

CommentIn: Infect Drug Resist. 2021 Oct 28;14:4501-4502. - PMID 34737590

109

Editorial : Enterobacteriaceae Antimicrobial Agents and Resistance: Relationship With the Therapeutic Approach

enthalten in: Frontiers in cellular and infection microbiology | 2021

von Mascellino, M. | Biswas, S. | Oliva, A.

110

"Overview of the Main Anti-SARS-CoV-2 Vaccines : Mechanism of Action, Efficacy and Safety" [Response To Letter

enthalten in: Infection and drug resistance | 2021

von Mascellino, M. | Di Timoteo, F. | De Angelis, M. | +1

CommentOn: Infect Drug Resist. 2021 Aug 31;14:3459-3476. - PMID 34511939